Research Article
RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer
Table 7
The agreement of mutant RAS detection from plasma, stool, and tissue samples in stage I to IV patients.
| | Stage | PPA | NPA | Overall agreement | | Plasma & tissue | Stool & tissue | Plasma & tissue | Stool & tissue | Plasma & tissue | Stool & tissue |
| | I | 33.3% (2/6) | 50% (3/6) | 0% (0/1) | 100% (1/1) | 28.6% (2/7, ) | 57.1% (4/7, ) | | II | 66.7% (4/6) | 85.7% (6/7) | 71.4% (5/7) | 85.7% (6/7) | 69.2% (9/13, ) | 84.6% (11/13, ) | | III | 75% (6/8) | 75% (6/8) | 100% (9/9) | 100% (9/9) | 88.2% (15/17, ) | 88.2% (15/17, ) | | IV | 80% (4/5) | 80% (4/5) | 100% (11/11) | 100% (11/11) | 93.8% (15/16, ) | 93.8% (15/16, ) |
|
|
